Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BIOD-961
- Development stage
- Phase 1
- Lead developer
- Ipsen
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Administration
- Intramuscular, Subcutaneous
01
Overview
BIOD-961 is a dry powder (lyophilized) formulation of glucagon developed for use in a proprietary auto-reconstitution device designed to simplify and expedite the emergency treatment of severe hypoglycemia. The product is intended to be mixed with liquid in the device immediately prior to administration, addressing challenges associated with traditional reconstitution procedures during emergencies. Mechanistically, BIOD-961 acts as an agonist at the glucagon receptor (GcGr), stimulating hepatic glucose production through glycogenolysis and gluconeogenesis. In clinical studies, its pharmacokinetic and pharmacodynamic profiles were shown to be bioequivalent to marketed injectable glucagon products such as Eli Lilly's Glucagon Emergency Rescue Kit and Novo Nordisk's GlucaGen HypoKit[1][3][7].
- Other names
- BIOD-961BIOD961BIOD 961stable glucagonlyophilized glucagon formulation
02
Targets
GCGR (Glucagon receptor)
Beyond the preview
Go deeper on BIOD-961.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIOD-961.